Accretion Pharmaceuticals IPO Allotment Status

Accretion Pharmaceuticals Limited, incorporated in 2012, is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products. The Accretion Pharmaceuticals IPO comes with a total issue size of ₹29.75 crore, comprising entirely a fresh issue of 29.46 lakh shares. The IPO opened on May 14, 2025, and closed on May 16, 2025. The allotment date for the Accretion Pharmaceuticals IPO is expected to be finalized on Monday, May 19, 2025.

Don’t Miss Out on the Next Big IPO – Invest With Just a Few Clicks!

Open Account Now

Steps to Check Accretion Pharmaceuticals IPO Allotment Status on Registrar Site

• Visit Kfin Technologies Limited website
• Select "Accretion Pharmaceuticals IPO" from the dropdown menu on the allotment status page
• Enter your PAN ID, Demat Account Number, or Application Number in the designated field
• Complete the captcha verification process and click on the "Submit" button to view your allotment status

Steps to Check Accretion Pharmaceuticals IPO Allotment Status on NSE

• Navigate to the NSE SME IPO Allotment Status Page
• Choose "Accretion Pharmaceuticals IPO" from the list of active IPOs in the dropdown menu
• Input your Application Number and PAN ID in the required fields
• Verify the captcha and click "Search" to check your allotment status

Accretion Pharmaceuticals IPO Subscription Status

Accretion Pharmaceuticals IPO received strong investor interest, being subscribed 7.67 times overall. Here is a category-wise breakdown of the subscription as of 6:19:58 PM on May 16, 2025:

• Retail Category: 10.54 times
• Qualified Institutional Buyers (QIB): 12.14 times
• Non-Institutional Investors (NII): 4.28 times
   

Utilization of IPO Proceeds

The funds raised through the IPO will be utilized as follows:

• Capital Expenditure: Purchase of new equipment/machineries and upgradation of existing manufacturing facility
• Debt Repayment: Repayment/prepayment of certain borrowings availed by the Company
• Working Capital: Funding working capital requirements
• General Corporate Purpose: Supporting various business initiatives

Business Overview

The company also offers contract manufacturing services. Accretion Pharmaceuticals manufactures and markets Tablets, Capsules, Oral Liquids, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), and Oral Powder (Sachet, Dry Syrup). The company holds ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005 certifications, reflecting its dedication to quality and environmental management systems. The manufacturing unit is located in Ahmedabad, Sanand, Gujarat, and the company has expanded its global footprint, marking its presence in more than 20 countries, including regions in Africa, Southeast Asia, and the Middle East, with a team of 83 employees (including 4 Executive Directors) on its payroll as of January 2025.